美敦力(MDT.US)旗下糖尿病业务MiniMed(MMED.US)启动赴美IPO 拟募资至多7.84亿美元

智通财经02-24

智通财经APP获悉，全球医疗器械巨头美敦力(MDT.US)旗下的糖尿病业务部门MiniMed Group(MMED.US)于当地时间周二正式迈出独立上市的关键一步。根据该公司向美国证券交易委员会(SEC)提交的最新S-1修订文件显示，MiniMed计划在纳斯达克全球精选市场挂牌上市，股票代码定为“MMED”。此次IPO计划发行2800万股普通股，每股定价区间设在25美元至28美元之间。若按照定价...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2613122857?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-24 21:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613122857","market":"sh","top_or_hot":-1,"title":"美敦力(MDT.US)旗下糖尿病业务MiniMed(MMED.US)启动赴美IPO 拟募资至多7.84亿美元","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，全球医疗器械巨头美敦力(MDT.US)旗下的糖尿病业务部门MiniMed Group(MMED.US)于当地时间周二正式迈出独立上市的关键一步。根据该公司向美国证券交易委员会(SEC)提交的最新S-1修订文件显示，MiniMed计划在纳斯达克全球精选市场挂牌上市，股票代码定为“MMED”。此次IPO计划发行2800万股普通股，每股定价区间设在25美元至28美元之间。若按照定价...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1406867.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美敦力(MDT.US)旗下糖尿病业务MiniMed(MMED.US)启动赴美IPO 拟募资至多7.84亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美敦力(MDT.US)旗下糖尿病业务MiniMed(MMED.US)启动赴美IPO 拟募资至多7.84亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-24 21:49 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1406867.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，全球医疗器械巨头美敦力(MDT.US)旗下的糖尿病业务部门MiniMed Group(MMED.US)于当地时间周二正式迈出独立上市的关键一步。根据该公司向美国证券交易委员会(SEC)提交的最新S-1修订文件显示，MiniMed计划在纳斯达克全球精选市场挂牌上市，股票代码定为“MMED”。此次IPO计划发行2800万股普通股，每股定价区间设在25美元至28美元之间。若按照定价...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1406867.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BQXX3C00.GBP","symbol_name":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1406867.html","article_id":"2613122857","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613122857","pubTimestamp":1771940988,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，全球医疗器械巨头美敦力旗下的糖尿病业务部门MiniMed Group于当地时间周二正式迈出独立上市的关键一步。此次IPO计划发行2800万股普通股，每股定价区间设在25美元至28美元之间。在资本结构安排上，美敦力在本次IPO完成后预计将保留MiniMed约90%的股权，若承销商充分行使超额配售选择权，则持股比例约为89%。在经历了2025年12月的秘密递表后，MiniMed目前的财务状况也随之披露。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK4585":"ETF&股票定投概念","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4566":"资本集团","MDT":"美敦力","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","BK4588":"碎股","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC"},"translate_title":"Medtronic's (MDT.US) diabetes business MiniMed (MMED.US) launches IPO in the United States to raise up to US $784 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1.5},"content_text":"智通财经APP获悉，全球医疗器械巨头美敦力(MDT.US)旗下的糖尿病业务部门MiniMed Group(MMED.US)于当地时间周二正式迈出独立上市的关键一步。根据该公司向美国证券交易委员会(SEC)提交的最新S-1修订文件显示，MiniMed计划在纳斯达克全球精选市场挂牌上市，股票代码定为“MMED”。此次IPO计划发行2800万股普通股，每股定价区间设在25美元至28美元之间。若按照定价区间的上限计算，此次首次公开募股的融资规模将达到7.84亿美元，而该业务部门的整体估值也将提升至约78.6亿美元。在资本结构安排上，美敦力在本次IPO完成后预计将保留MiniMed约90%的股权，若承销商充分行使超额配售选择权，则持股比例约为89%。面对德康医疗(DXCM.US)和雅培(ABT.US)等强劲对手，独立后的MiniMed将依靠高盛、美银证券、花旗和摩根士丹利等顶级投行组成的承销团队，力求通过资本市场助力其新一代血糖传感技术与自动化给药系统的研发与推广。此次IPO标志着美敦力自2024年5月宣布战略调整以来的重要里程碑。作为长期以来全球胰岛素泵市场的领导者，MiniMed的业务历史可追溯至1983年，并于2001年被美敦力以约33亿美元的价格收归旗下。随着医疗科技市场的演变，美敦力决定通过分拆糖尿病部门来简化企业架构，以便将核心资源集中于更高增长、高利润的领域。在经历了2025年12月的秘密递表后，MiniMed目前的财务状况也随之披露。尽管其在2025财年创造了约27亿至29亿美元的年收入，且拥有包括MiniMed 780G系统在内的先进胰岛素泵及连续血糖监测(CGM)产品线，但该业务目前仍处于净亏损状态。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2613122857","isCrawlerRequest":true}